IPO Overview: Omeros' IPO a Capital Effort for Its PharmacoSurgery Product Candidate [View article]
My broker sent me this prospectus but I stay away from any initial IPO where the holders are selling their stock. This is the case with OMER. I will watch this IPO and am willing to bet it will close below the offering price.
Procter & Gamble Plans to Sell Folgers to Smuckers: Win-Win? [View article]
As a Smucker's shareholder, I think this is a bad deal. They are paying a lot of money for a dying brand in an ere where younger people eschew the branded coffees of our parents. I will be selling (AFTER the $5 dividend).
Sort by:
Latest | Highest ratedWhy I Sold Coke and Bought Church & Dwight [View article]
Ten Products that Boomed During Recession [View article]
IPO Overview: Omeros' IPO a Capital Effort for Its PharmacoSurgery Product Candidate [View article]
Procter & Gamble Plans to Sell Folgers to Smuckers: Win-Win? [View article]
Retail Plays For Bad Times [View article]